Columnist Anna Jeter describes her fast, and perhaps uncommon, pulmonary hypertension diagnosis journey, which lasted about ...
November is Pulmonary Hypertension Awareness Month, and the American Lung Association, with support from Merck, is raising awareness about one form of the condition: pulmonary arterial hypertension ...
Pulmonary hypertension treatment can help slow disease progression, ease symptoms, and improve quality of life for people with the disease.
Not being able to catch your breath is scary, but shortness of breath can occur in a wide range of medical conditions, including high blood pressure and pulmonary hypertension. Share on Pinterest ...
A machine learning model using basic clinical data can predict PH risk, identifying key predictors like low hemoglobin and elevated NT-proBNP. Researchers have developed a machine learning model that ...
About 1% of the global population has pulmonary hypertension, which currently has no cure. The condition is more common in females, and scientists believe it may be due to the hormone estrogen.
Doctors in Germany could have achieved a breakthrough as they treated a young girl suffering from a severe pulmonary condition that can lead to heart failure, by applying umbilical cord stem cell ...
Tribune Content Agency on MSN

Mayo Clinic Q&A: Tips for living with COPD

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I’m ...
Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.
In treatment-naïve patients with PAH, initial monotherapy improves exercise capacity, hemodynamics, and outcomes when compared with those noted among untreated patients. In patients who are newly ...
Mere weeks after earning the FDA’s signoff on new drug Winrevair to treat pulmonary arterial hypertension (PAH), Merck has kicked off an educational campaign around the rare disease. The “Outnumber ...
Researchers estimate that about 1% of the global population has pulmonary hypertension — a disease caused by high blood pressure in the blood vessels that deliver oxygen to the lungs. Past studies ...